Professional Documents
Culture Documents
Brief Reports
Bacterial Aetiology and Anti-microbial Resistance of
Childhood Diarrhoea in Yemen
Summary
In a 12-month period, 561 stool cultures from Yemeni children aged 1–60 months and presenting
with diarrhoea, were analysed to identify the bacterial aetiology and their anti-microbial resistance
to the commonly used antibiotics. A total of 190 (33.9 per cent) were positive for bacterial culture.
Most of the positive cultures (58 per cent) were from children aged 1–12 months. The majority of
the positive cultures were enteropathogenic Escherichia coli (58.4 per cent) Salmonella spp., and
Shigella spp. (20 per cent each). Campylobacter were found to be an extremely uncommon agent of
childhood diarrhoea making only 1.6 per cent of the positive cultures. The majority of the Salmo-
nella were group C (60.5 per cent) and group B (29 per cent). Of the Shigella isolates, 13 (34 per
cent) were S. flexneri, and seven (18 per cent) S. dysentrea. More than two-thirds of the Salmonella
isolates were resistant to nalidixic acid, chloramphenicol, co-trimoxazole, gentamicin, and amoxy-
cillin, while 42 per cent were resistant to cefotaxime. Most of the Shigella isolates were susceptible
to nalidixic acid and cefotaxime, and resistant to the other antibiotics. All the tested enteropatho-
genic E. coli isolates were resistant to amoxycillin, 83 per cent were resistant to co-trimoxazole, 62
per cent to chloramphenicol, and 54 per cent to gentamicin, while only 16 and 6 per cent were resis-
tant to nalidixic acid and cefotaxime, respectively. This study, the first in Yemen, draws attention to
the urgent need of a national surveillance system, essential for the containment of anti-microbial
resistance.
Journal of Tropical Pediatrics Vol. 47 October 2001 Oxford University Press 2001 301
11brief reports 29/8/01 10:14 am Page 302
BRIEF REPORTS
TABLE 1
Childhood diarrhoea in Yemen: bacterial aetiology and age group distribution
Isolates Under 6 months (n = 136) 6–12 months (n = 162) 13–60 months (n = 263) Total (561)
TABLE 2
Bacterial aetiology of childhood diarrhoea in Yemen: total isolates tested (TIT) and antibiotic-resistant
isolates (RI)
Salmonella spp. 32 20 37 21 38 33 29 22 3 2 31 13
(62.5%) (77.8%) 86.4%) (76%) (42%)
Shigella spp. 31 6 23 12 37 31 25 12 2 2 31 2
(19.4%) (52%) (84%) (48%)
Enteropathogenic E. coli spp. 96 15 66 41 98 81 57 31 11 11 95 6
(15.6%) (62%) (82.6%) (54.4%) (100%) (6.3%)
Campylobacter spp. – – 1 0 2 2 4 2 3 0 1 0
were flexneri, seven dysentrea, four boydii, three evidence of bacteraemia, only expensive third-gener-
sonnie, and 10 were non-typable. Among the ation cephalosporin may be life saving, in addition to
enteropathogenic E. coli, nine were type 0114, six rehydration therapy. Also nalidixic acid would be the
type 044, four type 0125, three type 0126, three type only effective antibiotic for treating Shigella dysen-
0111, and two were type 0119. tery in the childhood community in Yemen.
Although the resistance rate of the common
pathogens can vary greatly over short distances,9 our
Discussion study draws attention to the urgent need for national
The results of this study showed that enteropatho- anti-microbial surveillance to be undertaken in
genic E. coli accounts for 58 per cent of all isolates Yemen.
and is the principal bacterial agent of diarrhoea in
children under 5 years in Yemen, which is similar to References
other studies.3,4 Campylobacter on the other hand
1. Central Statistical Organization (Yemen), Marco International
was found to be an extremely uncommon cause of
Inc. Yemen Demographic and Maternal and Child Health
childhood diarrhoea in Yemen (Table 1), in contrast Survey, 1997. Marco International, Calverton, MD, 1998.
with studies from neighbouring countries.5,6 2. Fauveau V, Yunus M, Zaman K, Chakraborty J, Sarder AM.
Malnutrition in Yemen stands among the highest Diarrhoea mortality in rural Bangladeshi children. J Trop Pediatr
in the world with 52 per cent of children aged under 1991; 37: 31–6.
5 years being stunted, and 46 per cent under weight,1 3. Levine MM. Escherichia coli that cause diarrhoea: enterotoxi-
making them vulnerable to developing bacteraemia genic, enteropathogenic, entero invasive, entero hemorrhagic
when they suffer bacterial diarrhoea. and entero adherent. J Infect Dis 1987; 155: 377–89.
The pattern of Shigella and enteropathogenic E. 4. Gomes TAT, Rassi V, MacDonald KL, et al. Enteropathogens
associated with acute diarrheal disease in urban infants in Sao
coli resistance to the commonly used antibiotics in
Paulo, Brazil. J Infect Dis 1991; 164: 331–37.
this study is comparable to those reported in other 5. Zaman R. Campylobacter enteritis in Saudi Arabia. Epidemiol
studies.7,8 The alarming high rate of resistant bacteria Infect 1992; 108: 51–8.
to the commonly used antibiotics is of great concern, 6. Gedlu E, Aseffa A. Campylobacter enteritis among children in
since in vulnerable malnourished children who are north-west Ethiopia: a 1-year prospective study. Ann Trop
hospitalized with complicated diarrhoea and Paediatr 1996; 16: 207–9.
BRIEF REPORTS
7. Malkawi HT, Youssef MT. Antibiotic susceptibility testing and 9. Wise R, Andrews JM. Local surveillance of anti-miocrobial
plasmid profiles of Escherichia isolated from diarrhoea patients. resistance. Lancet 1998; 352: 657–58.
J Trop Pediatr 1998; 44: 128–32.
8. Chopra M, Wilkinson D, Stirling S. Epidemic Shigella dysentry in
northern KwaZulu – Natal. S Afr Med J 1997; 87: 48–51.
Summary
In order to evaluate the prevalence rate of HBs antigen in children with a suspicion of HIV infec-
tion, 103 children were tested for HBs antigen and HIV. The mean age of the children was 2 years.
The prevalence of HBs antigen was 39.8 per cent in children and the HIV ELISA test was positive
in 57.7 per cent. A correlation was found between carrier of HBs antigen and HIV ELISA positiv-
ity (p = 0.04, RR = 1.46; 1.06 < RR < 2.02). There was a high prevalence of HBs antigen in children
with a suspicion of HIV infection. This calls for the promotion of antenal screening for HIV and
HBV along with immunization against hepatitis B in newborns in our setting.